Hemlibra in Mild Hemophilia A

NCT04567511 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Factor VIII Deficiency, Congenital

Interventions

DRUG: Emicizumab

Sponsor

Indiana Hemophilia &Thrombosis Center, Inc.

Collaborators

[object Object]